Ambe, Wilma A.
HRN: 24-03-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/05/2023
11/12/2023
IV
1.5gm
TID
Infected Wound
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes